Research suggests that Noxa plays a role in inhibiting oncogenesis in gastric cancer through ZNF519, but is suppressed by hsa-miR-200b-3p. Other studies have explored various biomarkers and mechanisms in gastric cancer and other related cancers, including the roles of different NOX genes and other molecular pathways. The relationship between these findings and Noxa's role in gastric cancer is not clearly defined.